We are a preclinical biomedical company that specializes in the development of safe and effective vaccines for emerging infectious diseases and cancer. We develop our vaccines by using novel vaccine technologies such as virus-like particles and genetic vectors. Medigen also develops new ways of vaccine delivery for effective and safe immunization.